Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 982 results for "hepatitis"

Gilead signs hepatitis C pact to cut drug cost for poor

Gilead to license Sovaldi

The big-cap biotech is licensing its megasuccessful hepatitis C drug Sovaldi to Indian generic-drug makers such as Ranbaxy Labs and Cipla, in addition to U.S.-based Mylan (MYL). One course of the Gilead Sciences (GILD) treatment is currently $84,000 ... Yahoo! Finance, 23 minutes ago
Access expands to Hepatitis C drug San Francisco Chronicle, 1 hour ago

751 images for hepatitis

Med India, 16 hours ago
The New Age Online, 6 hours ago
Hepatology, 2 days ago
Hepatology, 2 days ago
Pharmaceutical Journal, 5 days ago
RIA Novosti, 6 days ago
WCPO, 3 days ago
CNN, 7 hours ago
Irish Times, 1 week ago
CNBC, 1 week ago

Hope for 'cheap' hepatitis drug

New Delhi, Sept. 15: A US biopharmaceutical company today announced its move to make available a medicine to treat hepatitis C virus infections in India and 90 other developing countries at prices much lower than the treatment-course cost of $84,000 (Rs 51.3 ...
 The Telegraph1 hour ago

Gilead mulls price of next version of Sovaldi as Oregon says it's already too high

The $84,000 price tag of Gilead Sciences hepatitis C drug is raising eyebrows in Oregon and beyond, but the Foster City company says that the next generation of the drug may not cost significantly more. Next month, the U.S. Food and Drug ...
 San Francisco Chronicle2 hours ago Gilead To Boost Price Of New Hepatitis C Drug  Kaiser Health News9 hours ago New Hepatitis Drug Expected to Cost Near $100,000  NewsMax.com2 days ago Gilead to raise price for new hepatitis C drug above $84,000  Reuters3 days ago
Business Standard

Gilead Licenses Hepatitis Therapy in India Amid Price Criticism

Gilead Sciences Inc. The agreements allow Cadila Healthcare Ltd. (CDH), Cipla Ltd., Hetero Labs Ltd., Mylan Laboratories Ltd. The drug's pricing has drawn criticism from pharmacy benefit managers, as well as questions from U.S. Senators Charles ...
 BusinessWeek9 hours ago Zydus granted license to produce generic hepatitis C drug  Smart Investor11 hours ago Zydus gets Gilead licence for Hepatitis C treatment  Hindu Business Line11 hours ago Zydus Cadila bags license for hepatitis C drug  Business Standard11 hours ago

Generic Hepatitis C Drug Could Help 100 Million People Living with Disease

The brand-name version of the drug can cost as much as $1000 a pill, making it unaffordable to most who suffer from the contagious liver disease Gilead Sciences, a drug company that produces a highly effective but also highly expensive hepatitis C ...
 Time4 hours ago

7 Indian firms to make Hepatitis C drug

Comment · print · T T T+· T- TOPICS U.S. pharmaceutical major Gilead Sciences signs non-exclusive licensing agreements with these firms In a move to make the treatment for Hepatitis C more affordable in developing markets, U.S.
 The Hindu9 hours ago

Haemophiliacs seek access to new treatment

The Irish Haemophilia Society has called for early access to new treatments for 350 seriously ill patients with Hepatitis C. It says this group cannot medically tolerate the current Interferon-based treatments due to severe liver damage and the ...
 Irish Times12 hours ago Call for early access to Hep C treatments  RTE Online14 hours ago
Business Standard

Cipla at new high, eyes deal with Gilead for hepatitis drug

US-based drug maker Gilead Sciences may join hands with atleast five Indian generic pharmaceutical companies for manufacturing and selling cheaper versions of its new hepatitis C medicines.
 Money Control19 hours ago Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries  Business Standard1 day ago Gilead Sciences to Allow 5 Indian Firms to Sell Hepatitis Generics in 90 Countries  MedIndia16 hours ago Angel Broking remains neutral on Cipla and Cadila Healthcare  MyIris17 hours ago

Patients with Hepatitis C 'should have immediate access to potential life-saving therapies' - Irish Haemophilia Society

People seriously ill with Hepatitis C should have immediate access to new therapies which could save their lives. Too many of our members have died. We provide continued support to all our members with Hepatitis C, including to the 50 who were cured ...
 Irish Independent13 hours ago Patients with Hepatitis C should have immediate access to potential life-saving therapies - Irish Haemophilia Society  Big News Network3 hours ago Too many with haemophilia in Ireland have died  TheJournal.ie2 hours ago
Business Standard

Strides Arcolab promoter bags deals from Gilead

Tie-up aims to bring Hepatitis C cure to 91 developing countries Raghuvir Badrinath | Bangalore September 15, 2014 Last Updated at 20:37 IST Arun Kumar, the reclusive promoter of Bangalore-based Strides Arcolab and SeQuent Scientific, on Monday wrapped up two ...
 Business Standard12 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less